Clinical Updates

Drug approvals, guideline changes, and treatment advances

Engineered Islet Transplant Survives Without Immunosuppression in First-in-Human Trial

A first-in-human trial published in the New England Journal of Medicine demonstrates long-term survival of genetically engineered pancreatic islet cells…

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

More form Clinical Updates

Dexcom Signals Expansion Beyond Diabetes as CGM Technology Reshapes Health Monitoring

Dexcom's leadership has signalled plans to expand continuous glucose monitoring beyond diabetes management into weight…